Clinic-Based Characterization of Adolescents and Young Adults With Migraine: Psychological Functioning, Headache Days, and Disability.

IF 2.3 Q3 CLINICAL NEUROLOGY
Neurology. Clinical practice Pub Date : 2024-06-01 Epub Date: 2024-04-24 DOI:10.1212/CPJ.0000000000200294
Robert C Gibler, Maya A Marzouk, James Peugh, Brooke L Reidy, Michelle M Ernst, Morgan L Daffin, Scott W Powers, Marielle Kabbouche Samaha, Joanne Kacperski, Andrew D Hershey, Hope O'Brien, Shalonda K Slater
{"title":"Clinic-Based Characterization of Adolescents and Young Adults With Migraine: Psychological Functioning, Headache Days, and Disability.","authors":"Robert C Gibler, Maya A Marzouk, James Peugh, Brooke L Reidy, Michelle M Ernst, Morgan L Daffin, Scott W Powers, Marielle Kabbouche Samaha, Joanne Kacperski, Andrew D Hershey, Hope O'Brien, Shalonda K Slater","doi":"10.1212/CPJ.0000000000200294","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>This cross-sectional observational study retrospectively examined clinical data collected from adolescents and young adults (AYAs) seeking care in a specialty headache clinic. We characterized participants' headache characteristics and psychological functioning and examined the association between self-reported anxiety and depressive symptoms and headache frequency, severity, and disability.</p><p><strong>Methods: </strong>During their clinic visit, AYAs (<i>M</i> age = 18.36; range = 14-32, 79.5% female) completed an intake questionnaire and reported about their headache characteristics (i.e., frequency, severity, and duration of symptoms in months), mental health history (i.e., previous diagnosis of an anxiety or depressive disorder), and utilization of emergency department (ED) services for migraine. AYAs also completed psychometrically validated screening tools for anxiety and depressive symptoms (i.e., the GAD-7 and PHQ-9). We computed descriptive statistics and examined associations among scores on psychological measures and headache characteristics, including migraine-related disability. We also tested whether individuals with clinically elevated GAD-7 and PHQ-9 scores had higher levels of disability relative to those with fewer/subclinical levels of anxiety and depressive symptoms.</p><p><strong>Results: </strong>Participants (<i>N</i> = 283) reported more than 19 headache days per month on average, with more than 90% describing their average headache intensity as <i>moderate</i> or <i>severe</i>. Nearly half of AYAs reported severe headache-related disability. Approximately one-quarter of AYAs reported a previous diagnosis anxiety or depressive disorder diagnosis, and more than one-third scored above clinical cutoffs on the PHQ-9 and GAD-7. Higher scores on both psychological screening instruments were associated with greater headache frequency. More than 10% of patients endorsed current suicidal ideation; this was not related to headache-related disability. Participants reported a high degree of ED utilization for headache; these rates were unrelated to endorsement of psychological comorbidities.</p><p><strong>Discussion: </strong>In this sample of AYAs, headache characteristics were generally unrelated to scores on measures on psychological functioning. However, the observed rates of clinically elevated anxiety/depressive symptoms and suicidality in this sample of AYAs underscore the importance of screening for psychological comorbidities in neurology clinics that serve this age group, irrespective of self-reported disability. Results also emphasize the need to expand access to behavioral health services for AYAs with headache disorders and the importance of incorporating a biopsychosocial perspective to the transition of health care from pediatrics to adult neurology practice.</p>","PeriodicalId":19136,"journal":{"name":"Neurology. Clinical practice","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11052567/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology. Clinical practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1212/CPJ.0000000000200294","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/24 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objectives: This cross-sectional observational study retrospectively examined clinical data collected from adolescents and young adults (AYAs) seeking care in a specialty headache clinic. We characterized participants' headache characteristics and psychological functioning and examined the association between self-reported anxiety and depressive symptoms and headache frequency, severity, and disability.

Methods: During their clinic visit, AYAs (M age = 18.36; range = 14-32, 79.5% female) completed an intake questionnaire and reported about their headache characteristics (i.e., frequency, severity, and duration of symptoms in months), mental health history (i.e., previous diagnosis of an anxiety or depressive disorder), and utilization of emergency department (ED) services for migraine. AYAs also completed psychometrically validated screening tools for anxiety and depressive symptoms (i.e., the GAD-7 and PHQ-9). We computed descriptive statistics and examined associations among scores on psychological measures and headache characteristics, including migraine-related disability. We also tested whether individuals with clinically elevated GAD-7 and PHQ-9 scores had higher levels of disability relative to those with fewer/subclinical levels of anxiety and depressive symptoms.

Results: Participants (N = 283) reported more than 19 headache days per month on average, with more than 90% describing their average headache intensity as moderate or severe. Nearly half of AYAs reported severe headache-related disability. Approximately one-quarter of AYAs reported a previous diagnosis anxiety or depressive disorder diagnosis, and more than one-third scored above clinical cutoffs on the PHQ-9 and GAD-7. Higher scores on both psychological screening instruments were associated with greater headache frequency. More than 10% of patients endorsed current suicidal ideation; this was not related to headache-related disability. Participants reported a high degree of ED utilization for headache; these rates were unrelated to endorsement of psychological comorbidities.

Discussion: In this sample of AYAs, headache characteristics were generally unrelated to scores on measures on psychological functioning. However, the observed rates of clinically elevated anxiety/depressive symptoms and suicidality in this sample of AYAs underscore the importance of screening for psychological comorbidities in neurology clinics that serve this age group, irrespective of self-reported disability. Results also emphasize the need to expand access to behavioral health services for AYAs with headache disorders and the importance of incorporating a biopsychosocial perspective to the transition of health care from pediatrics to adult neurology practice.

青少年偏头痛患者的临床特征:心理功能、头痛天数和残疾。
背景和目的:这项横断面观察性研究回顾性地检查了在头痛专科门诊就诊的青少年和年轻成人(AYAs)的临床数据。我们描述了参与者的头痛特征和心理功能,并研究了自我报告的焦虑和抑郁症状与头痛频率、严重程度和残疾之间的关联:在就诊期间,青少年患者(平均年龄为 18.36 岁,年龄范围为 14-32 岁,79.5% 为女性)填写了一份就诊问卷,并报告了他们的头痛特征(即症状的频率、严重程度和持续时间,以月为单位)、心理健康史(即之前被诊断为焦虑症或抑郁症)以及因偏头痛而使用急诊科(ED)服务的情况。青少年还完成了经心理测试验证的焦虑和抑郁症状筛查工具(即 GAD-7 和 PHQ-9)。我们计算了描述性统计数字,并研究了心理测量得分与头痛特征(包括偏头痛相关残疾)之间的关联。我们还测试了临床上 GAD-7 和 PHQ-9 分数升高的人是否比焦虑和抑郁症状较少/处于亚临床水平的人残疾程度更高:参与者(N = 283)报告每月平均头痛天数超过 19 天,超过 90% 的参与者将其平均头痛强度描述为中度或重度。近一半的青少年报告了与头痛有关的严重残疾。约四分之一的青少年曾被诊断患有焦虑症或抑郁症,超过三分之一的青少年在 PHQ-9 和 GAD-7 中的得分高于临床临界值。这两种心理筛查工具的得分越高,头痛频率越高。10%以上的患者有自杀倾向,但这与头痛相关残疾无关。参与者报告说,他们因头痛而使用急诊室的比例很高;这些比例与心理并发症无关:讨论:在这一青少年样本中,头痛特征一般与心理功能测量得分无关。然而,在该样本中观察到的临床焦虑/抑郁症状升高率和自杀率强调了在为该年龄段人群提供服务的神经病学诊所中筛查心理合并症的重要性,无论其自我报告的残疾情况如何。研究结果还强调了为患有头痛疾病的青少年提供更多行为健康服务的必要性,以及将生物心理社会视角纳入从儿科到成人神经内科的医疗过渡的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neurology. Clinical practice
Neurology. Clinical practice CLINICAL NEUROLOGY-
CiteScore
4.00
自引率
0.00%
发文量
77
期刊介绍: Neurology® Genetics is an online open access journal publishing peer-reviewed reports in the field of neurogenetics. The journal publishes original articles in all areas of neurogenetics including rare and common genetic variations, genotype-phenotype correlations, outlier phenotypes as a result of mutations in known disease genes, and genetic variations with a putative link to diseases. Articles include studies reporting on genetic disease risk, pharmacogenomics, and results of gene-based clinical trials (viral, ASO, etc.). Genetically engineered model systems are not a primary focus of Neurology® Genetics, but studies using model systems for treatment trials, including well-powered studies reporting negative results, are welcome.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信